Author:
Anliker B.,Longhurst S.,Buchholz C.J.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference6 articles.
1. HSE (2007) The SACGM Compendium of guidance, Part 6: Guidance on the use of genetically modified microorganisms in a clinical setting. http://www.hse.gov.uk/biosafety/gmo/acgm/acgmcomp
2. Stanford MM, McFadden G (2005) The ‘supervirus’? Lessons from IL-4-expressing poxviruses. Trends Immunol 26:339–345
3. Favre D, Viret J-F (2006) Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation. Vaccine 24:3856–3864
4. Schenk-Braat EAM, van Mierlo MMKB, Wagemaker G et al (2007) An inventory of shedding data from clinical gene therapy trials. J Gene Med 9:910–921
5. Brandon EFA, Tiesjema B, van Ejikeren JCH, Hermsen HPH (2008) Effect of administration route on biodistribution and shedding of replication-deficient viral vectors used in gene therapy. A literature study. RIVM 320001001/2008
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献